Evidence map›Paper›PMID 41838222›Full record

ArticleDiscover oncology2026

Integrative bibliometrics and spatial transcriptomics identify CAF-associated genes and immune niches in hepatocellular carcinoma.

Cheng-Li Ma, Yu-Ping Ye, Ke-Jun Wu, Guo-Qiang Chen, Jian-Jia Zeng, Di-Yuan Qin, Dan-Dan Xiong, Ming-Jie Li, Qi Li, Min-Hua Rong and 7 more

Abstract read
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Cheng-Li Ma *Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.ORCID http://orcid.org/0009-0005-1943-9210
Yu-Ping Ye *Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Ke-Jun WuDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Guo-Qiang ChenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Jian-Jia ZengDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Di-Yuan QinDepartment of Computer Science and Technology, School of Computer and Electronic Information, Guangxi University, 100 Daxuedong RD, Nanning, 530004, Guangxi Zhuang Autonomous Region, PR China.
Dan-Dan XiongDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Ming-Jie LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Qi LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Min-Hua RongResearch Department, Guangxi Medical University Cancer Hospital, 71 Hedi Road, Nanning, 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Jin-Lian YaoDepartment of Pharmacy, Guangxi Medical University Cancer Hospital, No. 50 Liangyu Road, Wuxiang New District, Nanning, 530012, Guangxi Zhuang Autonomous Region, China.
Si-Yan ChenDay Chemotherapy Center, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Bang-Teng ChiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Yan-Kun NingDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Jing-Wen LingDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China.
Rong-Quan He *Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China. Herongquan@gxmu.edu.cn.
Gang Chen *Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang yong RD, Nanning, 530021, Guangxi Zhuang Autonomous Region, PR China. chengang@gxmu.edu.cn.

Funding

China Undergraduate Innovation and Entrepreneurship Training Program S202310598177Future Academic Star of Guangxi Medical University WLXSZX23110Guangxi Medical University "Four New" Project SX202403Guangxi Zhuang Autonomous Region Administration of Traditional Chinese Medicine Scientific Research Project GXZYA20230267Innovation Project of Guangxi Graduate Education JGY2023068Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation 2025GXNSFAA069130National Natural Science Foundation of China NSFC82460783Open Project of Guangxi Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer GXEKL202303
6 · The paper itself

Abstract

backgroundCancer-associated fibroblasts (CAFs), as a major stromal component of the tumor microenvironment (TME) in hepatocellular carcinoma (HCC), play critical roles in regulating tumor progression, immune evasion, and therapeutic responses. However, research on CAFs in HCC remains fragmented, and systematic synthesis with multidimensional mechanistic integration is still lacking.

objectiveThis study aims to systematically elucidate the key roles and mechanisms of CAFs in therapeutic resistance, metastasis, and immune microenvironment remodeling in HCC by integrating bibliometric analysis with multi-omics and spatial transcriptomic data.

methodsOriginal research articles related to CAFs and HCC were systematically retrieved from the Web of Science Core Collection. Bibliometric analyses were conducted using the R package Bibliometrix to assess annual publication trends, country- and institution-level collaboration networks, author and journal distributions, and keyword evolution patterns. In addition, transcriptomic datasets from GEO, TCGA, and ICGC, together with spatial transcriptomic data, were integrated to identify CAF-related differentially expressed genes, characterize their spatial localization, and evaluate correlations between CAF-related gene expression and immune cell infiltration, thereby exploring their potential biological functions.

resultsA total of 266 original studies were included. Since 2018, publications in the CAF–HCC field have increased markedly, accompanied by expanding international collaboration. Keyword analyses indicated that “resistance,” “metastasis,” “tumor microenvironment,” and “immune regulation” have remained central research themes. Mechanistic integration suggested that CAFs promote HCC stemness maintenance, immunosuppression, and pre-metastatic niche formation via pathways including TGF-β, IL-6/STAT3, and VEGFA. Multi-omics analyses identified 34 key genes commonly upregulated in both CAFs and HCC tissues. Spatial transcriptomic profiling further revealed that MMP9, SPP1, MMP12, and TREM2 exhibited pronounced spatial enrichment in tumor core regions and the tumor–stroma interface, with significant co-localization with immune cells such as macrophages and regulatory T cells. Among these, TREM2 showed the strongest positive correlation with macrophage infiltration, suggesting a potential role in CAF–immune cell crosstalk and the establishment of an immunosuppressive microenvironment in HCC.

conclusionCAFs exert multilayered and dynamic regulatory effects on therapeutic resistance, metastasis, and immune microenvironment remodeling in HCC.

Indexed as

Cancer-associated fibroblastsHepatocellular carcinomaMetastasis.Therapeutic resistanceTumor microenvironment

Identifiers

PMID41838222
PMCPMC13103047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.